About this course
Proprotein convertase subtilisin/kexin type 9 serine protease (PCSK9) is an enzyme that regulates low density
lipoprotein (LDL) receptor degradation. The gene for PCSK9 is implicated in patients with familial
hypercholesterolemia, and a gain-of-function mutation in that gene was found to be associated with high
LDL-cholesterol (LDL-C) levels.
PCSK9 inhibitors are monoclonal antibodies that prevent the degradation of LDL receptors thereby decreasing
LDL-C levels. This e-learning module discusses the biology behind PCSK9, the mechanism of PCSK9 inhibitors,
and when to use PCSK9 inhibitors for lipid-lowering management.
Learning outcomes
Upon completion of the educational activity, participants should be able to:
- Understand the role of PCSK9 in cholesterol metabolism and the mechanism of action of PCSK9 inhibitors
- Review the data behind drugs acting on PCSK9
- Enumerate the uses of PCSK9 inhibitors in current guidelines
Topics covered
- Introduction
- Biochemistry of PCSK9
- Drugs acting on PCSK9
- Review of Outcomes Trials of PCSK9 inhibitors & siRNA
- Current recommendations for use of PCSK9 inhibitors & siRNA
Speaker for this course:
 |
DR. Dick C.Y. Cheung
Specialist in Cardiology
|
Keywords: dyslipidemia, PCSK9, PCSK9 inhibitors, when to use PCSK9 inhibitors
1 CME Point Available
- This module is accredited for 1 CME Point for medical practitioners enrolled in The Medical Council
of
Hong Kong’s Continuing Medical Education Programme for Practising Doctors who are not taking CME
for
Specialists.
-
This module is accredited for both Hong Kong Doctors Union (HKDU) members and non-members.
- This module is accredited for 0.5 CME Point for fellows of the Hong Kong College of Physicians, Hong Kong College of Emergency Medicine, and Hong Kong College of Community Medicine.
- Please note that this module will not earn CME credit for fellows of colleges not
listed
here.
- A certificate can be downloaded upon successful completion of the quiz. Please use the information
on
the certificate to claim your CME points.